XML 28 R9.htm IDEA: XBRL DOCUMENT v3.19.1

Other Income	6 Months Ended
	Mar. 31, 2019
Component of Operating Income [Abstract]
Other Income	Note 3 Other Income Grant Income Clinical Study Grant During the year ended September 30, 2017, the Company was awarded grant funding in the amount of $597,886. The grant is being received in equal quarterly installments over a period of two years beginning during the year ended September 30, 2018 in exchange for a commitment to complete clinical testing for a therapeutic drug candidate for the treatment of Rett syndrome. The grant income is deferred when received and amortized to other income as the related research and development expenditures are incurred. During the three and six months ended March 31, 2019, the Company recognized $74,527 and $149,055, respectively (2018: $Nil and $Nil, respectively) of this grant on its statement of operations within grant income.

X

- Definition

Disclosure of other income disclosure.

+ References

No definition available.

+ Details

Name:	avxl_OtherIncomeDisclosureTextBlock
Namespace Prefix:	avxl_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_OtherIncomeAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration